ClinicalTrials.gov
public full text
Public Domain
Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
Study to assess the ability of healthy subjects to build anitbodies to tetanus and pneumococcal vaccines after receiving a single intravenous dose of Abatacept, a drug which is being developed for the treatment of Rheumatoid Arthritis and which can affect the immune system.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis#1045468
- Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis#812561
- Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)#842413
- Safety Study of Abatacept to Treat Rheumatoid Arthritis#1295547
- A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database#1293900
Record · ID 1362866
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive